PATENT CLAIM ANALYSIS

Application Number: 15740817
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "094000"]

Abstract:
A method for treating fatty liver disease in a patient in need thereof, including a step of administering an effective amount of zoledronic acid. The fatty liver disease includes fatty liver disease caused by foodborne and hereditary factors, in particular non-alcoholic fatty liver. A dosage form of the zoledronic acid is an injection, a solution, a tablet, or a capsule.

Claim (Index 5):
The use of zoledronic acid in preparing a drug for treating fatty liver disease according to  claim 1 , wherein the dosage of the zoledronic acid is 50 \u03bcg/kg or 200 \u03bcg/kg per injection, once every two days.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.61905
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13484246', '15564526', '13484241', '11378941', '14777001']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7734082039254185
- 35 USC 102 Novelty (BERT): 0.5151391212728444
- Combined Prediction Score: 0.7475812956601611
- Mean Citation Score: 255.11405200000004
- Max Citation Score: 278.49402000000003
- Similarity Product: 183.0972104695559

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test